{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:15:00Z","timestamp":1767838500082,"version":"3.49.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014978","name":"Hunan University of Chinese Medicine","doi-asserted-by":"publisher","award":["2022XYLH031\u53f7"],"award-info":[{"award-number":["2022XYLH031\u53f7"]}],"id":[{"id":"10.13039\/501100014978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274515\u53f7"],"award-info":[{"award-number":["82274515\u53f7"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Clinical co-occurrence of UC (Ulcerative Colitis) and T2DM (Type 2 Diabetes Mellitus) is observed. The aim of this study is to investigate the potential causal relationship between Ulcerative Colitis (UC) and Type 2 Diabetes Mellitus (T2DM) using LDSC and LAVA analysis, followed by genetic verification through TSMR, providing insights for clinical prevention and treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Genetic loci closely related to T2DM were extracted as instrumental variables from the GWAS database, with UC as the outcome variable, involving European populations. The UC data included 27,432 samples and 8,050,003 SNPs, while the T2DM data comprised 406,831 samples and 11,914,699 SNPs. LDSC and LAVA were used for quantifying genetic correlation at both global (genome-wide) and local (genomic regions) levels. MR analysis was conducted using IVW, MR-Egger regression, Weighted median, and Weighted mode, assessing the causal relationship between UC and diabetes with OR values and 95% CI. Heterogeneity and pleiotropy were tested using Egger-intercept, MR-PRESSO, and sensitivity analysis through the \u201cleave-one-out\u201d method and Cochran Q test. Subsequently, a reverse MR operation was conducted using UC as the exposure data and T2DM as the outcome data for validation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Univariable and bivariable LDSC calculated the genetic correlation and potential sample overlap between T2DM and UC, resulting in rg = -0.0518, se = 0.0562, <jats:italic>P<\/jats:italic> = 0.3569 with no significant genetic association found for paired traits. LAVA analysis identified 9 regions with local genetic correlation, with 6negative and 3 positive associations, indicating a negative correlation between T2DM and UC. MR analysis, with T2DM as the exposure and UC as the outcome, involved 34 SNPs as instrumental variables. The OR values and 95% CI from IVW, MR-Egger, Weighted median, and Weighted mode were 0.917 (0.848~0.992), 0.949 (0.800~1.125), 0.881 (0.779~0.996), 0.834(0.723~0.962) respectively, with IVW <jats:italic>P<\/jats:italic>-value &amp;lt; 0.05, suggesting a negative causal relationship between T2DM and UC. MR-Egger regression showed an intercept of -0.004 with a standard error of 0.009, <jats:italic>P<\/jats:italic> = 0.666, and MR-PRESSO Global Test <jats:italic>P<\/jats:italic>-value &amp;gt; 0.05, indicating no pleiotropy and no outliers detected. Heterogeneity tests showed no heterogeneity, and the \u201cleave-one-out\u201d sensitivity analysis results were stable. With UC as the exposure and T2DM as the outcome, 32 SNPs were detected, but no clear causal association was found.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There is a causal relationship between T2DM and UC, where T2DM reduces the risk of UC, while no significant causal relationship was observed from UC to T2DM.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1375915","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:47:48Z","timestamp":1732258068000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Global and regional genetic association analysis of ulcerative colitis and type 2 diabetes mellitus and causal validation analysis of two-sample two-way Mendelian randomization"],"prefix":"10.3389","volume":"15","author":[{"given":"Yan-zhi","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-han","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-ni","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/nejme1616575","article-title":"Increase in the incidence of diabetes and its implications","volume":"376","author":"Ingelfinger","year":"2017","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1017\/s0029665109990218","article-title":"Chemotactic cytokines, obesity and type 2 diabetes:in vivoandin vitroevidence for a possible causal correlation","volume":"68","author":"Sell","year":"2009","journal-title":"Proc Nutr Soc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0026-0495(98)90005-1","article-title":"Impaired glucose handling in active rheumatoid arthritis: Relationship to peripheral insulin resistance","volume":"37","author":"Svenson","year":"1988","journal-title":"Metabolism-clinical Exp"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2015.101","article-title":"Exercise and type 2 diabetes: focus on metabolism and inflammation","volume":"94","author":"Karstoft","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.10169","article-title":"Effect of an intensive lifestyle intervention on glycemic control in patients with type 2 diabetes","volume":"318","author":"Johansen","year":"2017","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20210316-00216","article-title":"The standard diagnosis and treatment of ulcerative colitis","volume":"60","author":"Yan","year":"2021","journal-title":"Chin J Internal Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis","volume":"49","author":"Du","year":"2020","journal-title":"Gastroenterol Clinics North America"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Berre","year":"2023","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.106842","volume-title":"Etiology of Ulcerative Colitis","author":"Preda","year":"2022"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-99-1316-9_10","article-title":"Network pharmacology and systems biology in drug discovery","author":"Shah","year":"2023","journal-title":"null"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cgh.2022.09.031","article-title":"Food processing and risk of crohn\u2019s disease and ulcerative colitis: A european prospective cohort study","volume":"21","author":"Meyer","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrgastro.2011.96","article-title":"Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis","volume":"8","author":"Thorsteinsdottir","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell\u2019s functional organization","volume":"5","author":"Barab\u00e1si","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1186\/s12866-016-0869-2","article-title":"Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora","volume":"16","author":"Yao","year":"2016","journal-title":"BMC Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat Rev Drug Discovery"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1228","article-title":"Global mapping of pharmacological space","volume":"24","author":"Paolini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1186\/1472-6904-5-3","article-title":"Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)","volume":"5","author":"Mencher","year":"2005","journal-title":"BMC Clin Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2006.01.013","article-title":"Can we rationally design promiscuous drugs","volume":"16","author":"Hopkins","year":"2006","journal-title":"Curr Opin Struct Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2174\/156802606778194226","article-title":"Rethinking target discovery in polygenic diseases","volume":"6","author":"Flordellis","year":"2006","journal-title":"Curr Topics Medicinal Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/157340908784533229","article-title":"On the paradigm shift towards multitarget selective drug design","volume":"4","author":"Dessalew","year":"2008","journal-title":"Curr Comput - Aided Drug Design"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3406","article-title":"An atlas of genetic correlations across human diseases and traits","volume":"47","author":"Bulik-Sullivan","year":"2015","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01017-y","article-title":"An integrated framework for local genetic correlation analysis","volume":"54","author":"Werme","year":"2022","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000741","article-title":"Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events","volume":"3","author":"Shah","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.23068","article-title":"Association between depressive symptoms and incident cardiovascular diseases","volume":"324","author":"Harshfield","year":"2020","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/00006842-199603000-00001","article-title":"Major depression before and after myocardial infarction","volume":"58","author":"Lesp\u00e9rance","year":"1996","journal-title":"Psychosomatic Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.14.5.388","article-title":"The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression","volume":"14","author":"Frasure-Smith","year":"1995","journal-title":"Health Psychol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114099","article-title":"Serum selenium and the risk of coronary heart disease and stroke","volume":"122","author":"Virtamo","year":"1985","journal-title":"Am J Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0021-9150(92)90035-f","article-title":"Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males","volume":"96","author":"Suadicani","year":"1992","journal-title":"Atherosclerosis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cgh.2019.07.052","article-title":"Inflammatory bowel diseases increase risk of type 2 diabetes in a nationwide cohort study","volume":"18","author":"Jess","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B39","article-title":"Systematic review and meta-analysis of the association between inflammatory bowel disease and diabetes mellitus","volume":"44","author":"Wu","year":"2021","journal-title":"Chin J Postgraduate Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030343","article-title":"Increased risk of diabetes in inflammatory bowel disease patients: A nationwide population-based study in korea","volume":"8","author":"Kang","year":"2019","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.09.016","article-title":"Association between inflammatory bowel disease and diabetes mellitus","volume":"18","author":"Lai","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2022.06.007","article-title":"The risk of type 2 diabetes in patients with inflammatory bowel disease after bowel resections: A nationwide cohort study","volume":"1","author":"Allin","year":"2022","journal-title":"Gastro Hep Adv"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbacli.2015.11.002","article-title":"Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links","volume":"5","author":"Jurjus","year":"2016","journal-title":"BBA Clin"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051434","article-title":"Connecting the dots between inflammatory bowel disease and metabolic syndrome: A focus on gut-derived metabolites","volume":"12","author":"Verdugo-Meza","year":"2020","journal-title":"Nutrients"},{"key":"B45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/ecco-jcc\/jjaa136","article-title":"Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus","volume":"15","author":"Tseng","year":"2021","journal-title":"J Crohns Colitis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1042\/cs20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2011","journal-title":"Clin Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6222","article-title":"Metformin exerts anti\u2212inflammatory effects on mouse colon smooth muscle cells in vitro","author":"Al-Dwairi","year":"2018","journal-title":"Exp Ther Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e0168670","DOI":"10.1371\/journal.pone.0168670","article-title":"Metformin improves ileal epithelial barrier function in interleukin-10 deficient mice","volume":"11","author":"Xue","year":"2016","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13342","article-title":"Metformin protects against intestinal barrier dysfunction via AMPK\u03b11-dependent inhibition of JNK signalling activation","volume":"22","author":"Deng","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02754","article-title":"Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan post-biotics in inflammatory bowel disease","volume":"10","author":"Russo","year":"2019","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02259","article-title":"Administration of akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice","volume":"10","author":"Bian","year":"2019","journal-title":"Front Microbiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcjd.2019.05.008","article-title":"Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice","volume":"44","author":"Ryan","year":"2020","journal-title":"Can J Diabetes"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"Mccreight","year":"2016","journal-title":"Diabetologia"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.229","article-title":"GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide","volume":"16","author":"Elahi","year":"2008","journal-title":"Obesity"},{"key":"B55","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"},{"key":"B56","volume-title":"Protective Effect and Mechanism of Glp-1 on Diabetes Mellitus Complicated With Chronic Colitis [D]","author":"Wang","year":"2022"},{"key":"B57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.21608\/ajps.2020.86014","article-title":"EXPERIMENTAL ULCERATIVE COLITIS: TGF-\u03b2 AS A DIAGNOSTIC MARKER","volume":"61","author":"Farghaly","year":"2020","journal-title":"Al-Azhar J Pharm Sci"},{"key":"B58","volume-title":"The Role and Potential Therapeutic Mechanisms of Irisin in UC Mice","author":"Huang","year":"2019"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/746281","article-title":"Irisin, two years later","volume":"2013","author":"Novelle","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2013.09.013","article-title":"Irisin in patients with nonalcoholic fatty liver disease","volume":"63","author":"Polyzos","year":"2014","journal-title":"Metabolism-clinical Exp"},{"key":"B61","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cryobiol.2015.10.143","article-title":"The whole body cryostimulation modifies irisin concentration and reduces inflammation in middle aged, obese men","volume":"71","author":"Dulian","year":"2015","journal-title":"Cryobiology"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.963","article-title":"Irisin precursor FNDC5 and glycemic control in patients with type 2 diabetes","author":"Lima M\u00e1gero","year":"2021","journal-title":"J Endocrine Soc"},{"key":"B63","article-title":"Relationship between transforming growth factor beta 1 and peripheral neuropathy in type 2 diabetic","author":"Li","year":"2013","journal-title":"Beijing Med J"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.275474","article-title":"Noninvasive method of differentiating diabetic nephropathy and nondiabetic renal disease using serum bone morphogenetic protein-7 and transforming growth factor-beta 1 levels in patients with type-2 diabetes mellitus","volume":"30","author":"John","year":"2019","journal-title":"Saudi J Kidney Dis Transplant"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1375915\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:47:56Z","timestamp":1732258076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1375915\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2024.1375915"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1375915","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"article-number":"1375915"}}